152 related articles for article (PubMed ID: 34924268)
81. Infection and medication-related osteonecrosis of the jaw.
Katsarelis H; Shah NP; Dhariwal DK; Pazianas M
J Dent Res; 2015 Apr; 94(4):534-9. PubMed ID: 25710950
[TBL] [Abstract][Full Text] [Related]
82. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
[TBL] [Abstract][Full Text] [Related]
83. Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
Support Care Cancer; 2022 Mar; 30(3):2341-2348. PubMed ID: 34738163
[TBL] [Abstract][Full Text] [Related]
84. Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy.
Al Abdullateef A; Alhareky MS
Saudi Pharm J; 2020 Jun; 28(6):771-778. PubMed ID: 32550810
[TBL] [Abstract][Full Text] [Related]
85. Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
van Cann T; Loyson T; Verbiest A; Clement PM; Bechter O; Willems L; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Debruyne PR; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B
Support Care Cancer; 2018 Mar; 26(3):869-878. PubMed ID: 28963584
[TBL] [Abstract][Full Text] [Related]
86. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
87. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
Yüce MO; Adalı E; Işık G
Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
[TBL] [Abstract][Full Text] [Related]
88. Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw.
Chopra K; Malhan N
Am J Ther; 2020 Jun; 28(4):e469-e477. PubMed ID: 32618592
[TBL] [Abstract][Full Text] [Related]
89. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
90. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
[TBL] [Abstract][Full Text] [Related]
91. The impact of medication-related osteonecrosis of the jaws on the quality of life in cancer patients.
Caminha RD; Alcantara PL; Carvalho CG; Reia VC; Capelozza AL; Santos PS
J Clin Exp Dent; 2020 Aug; 12(8):e725-e729. PubMed ID: 32913568
[TBL] [Abstract][Full Text] [Related]
92. Surgical Management of Medication-Related Osteonecrosis of the Jaw Is Associated With Improved Disease Resolution: A Retrospective Cohort Study.
El-Rabbany M; Lam DK; Shah PS; Azarpazhooh A
J Oral Maxillofac Surg; 2019 Sep; 77(9):1816-1822. PubMed ID: 31054989
[TBL] [Abstract][Full Text] [Related]
93. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
Kün-Darbois JD; Fauvel F
Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
[TBL] [Abstract][Full Text] [Related]
94. Evaluation of the sarcopenia quality of life (SarQoL) questionnaire in community dwelling outpatient postmenopausal hungarian women.
Pap Z; Kalabiska I; Balogh Á; Bhattoa HP
BMC Musculoskelet Disord; 2023 Apr; 24(1):331. PubMed ID: 37106363
[TBL] [Abstract][Full Text] [Related]
95. Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study.
Winter A; Schulz SM; Schmitter M; Brands RC; Straub A; Kübler A; Borgmann A; Hartmann S
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141982
[TBL] [Abstract][Full Text] [Related]
96. Treatment of Refractory Medicine Related Osteonecrosis of Jaw With Piezosurgical Debridement and Autologous Platelet Rich Fibrin: Feasibility Study.
Gurav S; Dholam KP; Singh GP
J Craniofac Surg; 2022 May; 33(3):e226-e230. PubMed ID: 34310422
[TBL] [Abstract][Full Text] [Related]
97. Are Bacteria Just Bystanders in the Pathogenesis of Inflammatory Jaw Conditions?
He P; Francois K; Missaghian N; Le AD; Flynn TR; Shanti RM
J Oral Maxillofac Surg; 2022 Jun; 80(6):1094-1102. PubMed ID: 35405094
[TBL] [Abstract][Full Text] [Related]
98. Improvement of Quality of Life after Surgical Treatment of Patients with MRONJ: A Prospective Analysis Using the SF-12 and OHIP-14 Questionnaires.
Hoene G; von Hahn N; Sievers D; Schuffelen L; Wolfer S; Goldstein K; Schminke B; Brockmeyer P; Kauffmann P
Int J Dent; 2024; 2024():4435791. PubMed ID: 38715871
[TBL] [Abstract][Full Text] [Related]
99. Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case-Control Pilot Study.
Calabria E; Antonelli A; Barone S; Adamo D; Salviati M; Cerra MG; Bennardo F; Giudice A
Dent J (Basel); 2023 Jun; 11(6):. PubMed ID: 37366670
[TBL] [Abstract][Full Text] [Related]
100. Development and validation of the Kidney Transplantation and Quality of Life, a Korean questionnaire to assess the general quality of life and other health issues associated with medication change in kidney transplant recipients.
Rhu J; Lee KW; Chung YJ; Park JB; Choi JY; Kim SJ; Jung JS; Kim S
Korean J Transplant; 2019 Dec; 33(4):135-145. PubMed ID: 35769972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
